Topical 0.3% ciprofloxacin vs topical 0.3% ofloxacin in early treatment of Pseudomonas aeruginosa keratitis in a rabbit model

Annals of Ophthalmology

Volumn 33, Issue 1, 2001, Pages 48-52

  LaBorwit, Scott E ^a   Katz, Harold R ^a   Hirschbein, Marc J ^a   Oswald, Michael R ^a   Snyder, Lori S ^a   Schwartz, Ken S ^a   Herling, Irvin E ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; OFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; KERATITIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; RABBIT;

EID: 0034878766     PISSN: 15304086     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12009-001-0055-4     Document Type: Article

References (29)

1. Initial therapy of suspected microbial corneal ulcers. I: Broad antibiotic therapy based on prevalence of organisms. II: Specific antibiotic therapy based on corneal smears
2. The role of cultures in the management of ulcerative keratitis
3. Bacterial keratitis
4. Microbiology aspects of fluoroquinolones
5. Toxic effects of antimicrobials on the ocular surface of healthy volunteers
6. The fluoroquinolones: Structures, mechanisms of action and reistance, and spectra of activity in vitro
7. Ciprofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
8. In vitro activity of the new fluoroquinolone CP-99,219
9. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified, tobramycincefazolin in treating bacterial corneal ulcers
10. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis
11. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis
12. The cornea-destroying enzyme of Pseudomonas aeruginosa
13. Mechanism of corneal destruction by Pseudomonas proteases
14. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis
15. Comparison of topical ciprofloxacin to conventional antibiotic therapy, in the treatment of ulcerative keratitis
16. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis
17. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model
18. A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa
19. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in the treatment in bacterial keratitis: A new method for comparative evaluation of ocular drug penetration
20. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye
21. The inhibitory quotient: A method for interpreting minimum inhibitory concentration data
22. Corneal tissue levels of topically applied ciprofloxacin
23. Intracorneal aqueous humor, and vitreous humo penetration of topical and oral ofloxacin
24. Resistant Pseudomonas keratitis
25. Gentamicin-resistant Pseudomonas aeruginosa corneal ulcers
26. Platinum spatula versus mini-tip culturette in culturing bacterial keratitis
27. Applications of therapy in animal models to bacterial infection in human disease